FY2025 · ended Dec 31, 2025 · Revenue $3.88M, -41.1% YoY · Filed Mar 31, 2026
Target Group Inc. (CBDY) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.9 million and a net loss of $1.4 million. As of Jun 30, 2026 it held $5,914 in cash and investments and $8.2 million in total debt.
Revenue (TTM)
$3.50M
-30.7% vs year-ago TTM
Net income (TTM)
$-1.82M
-184.2% vs year-ago TTM
Operating cash flow (TTM)
$-1.07M
-433.8% vs year-ago TTM
Free cash flow
$-1.48M
EPS (TTM)
$-0.00
-235.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
617.03M
+0.0% vs prior year
Net cash
$-8.24M
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hamilton
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1586554
- Former names
- Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.9M | $6.6M | $3.7M | — | $0 |
| Net income | -$1.4M | $160,504 | -$323,670 | -$4.5M | $272,881 |
| Diluted EPS | -$0.00 | $0.00 | -$0.00 | -$0.01 | $0.00 |
| Operating cash flow | -$842,425 | $2.2M | -$589,612 | -$1.0M | $100,118 |
| Total assets | $6.2M | $7.6M | $8.8M | $7.6M | $13.1M |
| Total liabilities | $14.2M | $14.1M | $15.8M | $14.1M | $15.2M |
| Stockholders' equity | -$8.1M | -$6.5M | -$7.0M | -$6.6M | -$2.2M |
| Cash and investments | $100,410 | $1.9M | $736,323 | $223,843 | $113,079 |
| Total debt | $8.6M | $8.4M | $9.2M | $9.1M | $10.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
New debt
|
Aug 18, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
All 254 Target Group Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.